rs777686211

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001384732.1(CPLANE1):​c.1819delT​(p.Tyr607fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.000178 in 1,539,856 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β˜…β˜…). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

CPLANE1
NM_001384732.1 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:18

Conservation

PhyloP100: 4.24
Variant links:
Genes affected
CPLANE1 (HGNC:25801): (ciliogenesis and planar polarity effector complex subunit 1) The protein encoded by this gene has putative coiled-coil domains and may be a transmembrane protein. Defects in this gene are a cause of Joubert syndrome (JBTS). [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-37226775-TA-T is Pathogenic according to our data. Variant chr5-37226775-TA-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 217590.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-37226775-TA-T is described in Lovd as [Pathogenic]. Variant chr5-37226775-TA-T is described in Lovd as [Likely_pathogenic]. Variant chr5-37226775-TA-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CPLANE1NM_001384732.1 linkuse as main transcriptc.1819delT p.Tyr607fs frameshift_variant 12/53 ENST00000651892.2 NP_001371661.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CPLANE1ENST00000651892.2 linkuse as main transcriptc.1819delT p.Tyr607fs frameshift_variant 12/53 NM_001384732.1 ENSP00000498265.2 A0A494BZW6

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152060
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000324
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000161
AC:
23
AN:
142536
Hom.:
0
AF XY:
0.000226
AC XY:
17
AN XY:
75282
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000236
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000975
Gnomad SAS exome
AF:
0.0000518
Gnomad FIN exome
AF:
0.000123
Gnomad NFE exome
AF:
0.000231
Gnomad OTH exome
AF:
0.000253
GnomAD4 exome
AF:
0.000179
AC:
248
AN:
1387796
Hom.:
0
Cov.:
32
AF XY:
0.000196
AC XY:
134
AN XY:
683914
show subpopulations
Gnomad4 AFR exome
AF:
0.0000974
Gnomad4 AMR exome
AF:
0.000211
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000130
Gnomad4 FIN exome
AF:
0.000285
Gnomad4 NFE exome
AF:
0.000198
Gnomad4 OTH exome
AF:
0.000174
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152060
Hom.:
0
Cov.:
32
AF XY:
0.000135
AC XY:
10
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000944
Gnomad4 NFE
AF:
0.000324
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000145
Hom.:
0
Bravo
AF:
0.000193

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:18
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:6
Pathogenic, criteria provided, single submitterclinical testingGeneDxFeb 07, 2024Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28125082, 34008892, 26092869, 34313030, Shelby[2022]casereport) -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2024CPLANE1: PVS1, PM2, PM3 -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 13, 2021This sequence change creates a premature translational stop signal (p.Tyr607Thrfs*6) in the CPLANE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPLANE1 are known to be pathogenic (PMID: 24178751, 26092869). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with Joubert syndrome (PMID: 26092869, 28125082). ClinVar contains an entry for this variant (Variation ID: 217590). For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingClinical Genetics Laboratory, Skane University Hospital LundSep 23, 2022- -
Pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Pathogenic, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Joubert syndrome 17 Pathogenic:5
Likely pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterJan 01, 2019This variant was identified as compound heterozygous. -
Pathogenic, criteria provided, single submitterresearchUW Hindbrain Malformation Research Program, University of WashingtonFeb 23, 2015- -
Pathogenic, criteria provided, single submitterclinical testingMendelicsSep 15, 2020- -
Pathogenic, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 26, 2015- -
Pathogenic, criteria provided, single submitterclinical testingLaboratory of Medical Genetics, National & Kapodistrian University of AthensAug 10, 2021PVS1, PM2, PP3, PP5 -
Orofaciodigital syndrome type 6;C3553264:Joubert syndrome 17 Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingNew York Genome CenterFeb 05, 2021- -
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJun 30, 2021- -
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsSep 02, 2021The c.1819delT (p.Y607Tfs*6) alteration, located in exon 12 (coding exon 11) of the C5orf42 gene, consists of a deletion of one nucleotide at position 1819, causing a translational frameshift with a predicted alternate stop codon after 6 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been reported in the compound heterozygous state with a second C5orf42 alteration in a patient with Joubert syndrome (Bachmann-Gagescu, 2015). Based on the available evidence, this alteration is classified as pathogenic. -
Nephronophthisis Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingSydney Genome Diagnostics, Children's Hospital WestmeadMay 31, 2018This patient is heterozygous for a likely pathogenic variant, c.1819del, in the C5orf42 gene. c.1819del (dbSNP: rs777686211) has been reported in the ExAC database (http://exac.broadinstitute.org/) with a low allele frequency of 0.024% (5/20526 alleles) and has also been reported as a compound heterozygous variant in a patient with Joubert syndrome (Bachmann-Gagescu et al. J.Med.Genet 2015; 52:514-522). This frameshifting variant is predicted to create a premature stop codon (p.Tyr607Thrfs*6) and may result in a null allele due to nonsense-mediated mRNA decay. This variant is considered to be a likely pathogenic according to the ACMG guidelines. -
Jaundice;C0557874:Global developmental delay Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingCentre for Mendelian Genomics, University Medical Centre LjubljanaNov 28, 2013- -
Orofaciodigital syndrome type 6 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingCentre for Mendelian Genomics, University Medical Centre LjubljanaApr 18, 2019This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5. -
CPLANE1-related disorder Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 08, 2024The CPLANE1 c.1819delT variant is predicted to result in a frameshift and premature protein termination (p.Tyr607Thrfs*6). This variant has previously been reported in the compound heterozygous state in individuals with Joubert syndrome (Bachmann-Gagescu et al. 2015. PubMed ID: 26092869; Table 1, Vilboux T et al 2017. PubMed ID: 28125082). This variant is reported in 0.024% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in CPLANE1 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs777686211; hg19: chr5-37226877; API